New search | Conferencedetail
Print view
 
 

2nd Anti-Fibrotic Drug Development Summit (AFDD)

evvnt Platform / evvnt
-
27.11.2018 - 29.11.2018  Hyatt Regency Cambridge, 575 Memorial Drive, 02139 Cambridge, Massachusetts, USA
Time: 8:00 am - 5:30 pm
 
Conference themes
AFDD (Anti-Fibrotic Drug Development) is the industry definitive fibrosis forum for drug developers focused on organ specific indications to gain cross-disciplinary insights into the next generation of candidates.

Join fibrosis leaders as they address challenges in anti-fibrotic drug development through a tighter lens.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Alexey Lugovsky, Chief Development Officer Morphic, Therapeutics, Andy Blanchard, Director External Discovery, GSK, Charles Theuer, Chief Executive Officer, Tracon Pharmaceuticals
 

Enquiries and Registration:

https://go.evvnt.com/263771-1?pid=4832
Ms. Aarti Diwan
 
Categories
Health Services, Pharmacology and Toxicology
Languages
English
Congress fees
USD 2.799,00
(Conference (Standard): USD 2799.0 Conference (Early bird ends Friday August 24, 2018): USD 2499.0 Conference (Early bird ends Friday September 21, 2018): USD 2599.0 Conference (Early bird ends Friday October 19, 2018): USD 2699.0)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Health Forum GasteinÄrzte der WeltÖsterreichische Gesellschaft für Public HealthAMREF - African Medical and Research FoundationAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Swiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation newTree

Facebook

Give us your professional opinion

Start survey

Start survey